Given this observation and our findings from the TCGA dataset, it is highly likely that a reduction of GYLTL1B expression is a frequent causative event in αDG hypoglycosylation in ccRCC, consistent with our previous findings in prostate cancer [22]. This evidence concerns the gene LARGE2 and prostate cancer.